Your Guide to Better Health
Get expert insights, health tips, and the latest updates in metabolic wellness — all in one place.
Lifestyle & Healthy HabitsExercise in a Vial? What MOTS-c Research Tells Us About Metabolic Peptides as Activity Mimetics
MOTS-c exercise mimetic peptide research is reshaping how clinicians think about sedentary metabolic decline. This article breaks down the AMPK science, what preclinical and human data actually show, and why this matters for metabolically compromised adults who struggle to exercise.
Dr. Jossy Onwude, MDMay 27, 202613 min read
LongevityMOTS-c: The Mitochondrial Peptide That Could Redefine Insulin Resistance and Metabolic Health
MOTS-c peptide metabolic health research is pointing to a mitochondrial-derived signal your body already produces — one that declines with age and worsens insulin resistance. This pillar guide explains how MOTS-c activates the AMPK pathway, what the human and animal evidence shows, which patients may benefit, and how to assess your metabolic baseline before exploring peptide therapy.
Editorial TeamMay 27, 202615 min read
Hormones & MetabolismPCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1
The PCAC peptide review 2026 is the most consequential regulatory event for compounded peptide therapy. On July 23–24, the FDA's advisory panel will formally evaluate BPC-157 and TB-500 for 503A Bulks List inclusion. This deep dive explains the regulatory timeline, what FDA is actually reviewing, what Thymosin Alpha-1's separate PCAC history means, and how each possible outcome affects your care.
Karyn O.May 26, 202614 min read
Hormones & MetabolismGray Market vs. Now-Legal Peptides: How to Safely Navigate Access and Avoid Dangerous Sources in 2026
The gray market peptide vs legal compounded 2026 landscape has shifted dramatically. This guide breaks down exactly what gray market peptides are, why research peptide risks are higher than most users realize, how to get legal peptides through a licensed compounding pharmacy, and what compounding pharmacy peptide safety standards actually require — so you can access therapy safely.
Lilian E.May 26, 202612 min read
Hormones & MetabolismHow to Start Growth Hormone Peptide Therapy: What Labs to Order First
Growth hormone peptide therapy labs are the non-negotiable first step before starting any GH secretagogue protocol. This guide covers every baseline test to order — IGF-1, fasting insulin, HbA1c, liver enzymes, thyroid, and more — explains what each result reveals about your GH axis, and shows what your clinician is looking for before prescribing CJC-1295, ipamorelin, tesamorelin, or sermorelin.
Dr. Jossy Onwude, MDMay 25, 202611 min read
Lifestyle & Healthy HabitsThe Complete Peptide Therapy Starter Guide: From First Question to First Injection
Wondering how to start peptide therapy but don't know where to begin? This complete beginner's guide covers baseline labs, choosing a qualified clinician, selecting the right peptide for your goal, sourcing safely, and what to expect in your first 12 weeks — all backed by clinical evidence.
Dr. Priyali Singh, MDMay 25, 202614 min read
Lifestyle & Healthy HabitsPeptide Therapy Providers in 2026 Compared: What to Look For in a Legitimate Clinic
Shopping for the best peptide therapy provider comparison in 2026? This guide covers the 6 non-negotiables every legitimate clinic must meet, how telehealth compares to in-person care, what insurance actually covers, and how to spot red flags before you book.
Dr. Priyali Singh, MDMay 22, 202614 min read
Hormones & MetabolismPT-141 (Bremelanotide): The Peptide for Hormonal and Sexual Health
PT-141 (bremelanotide) is the only FDA-approved non-hormonal peptide for female sexual desire disorder. This deep dive covers the melanocortin mechanism, RECONNECT Phase 3 trial data, how hormonal conditions like PMOS and perimenopause intersect with low libido, who qualifies for treatment, and what the safety profile actually shows.
Editorial TeamMay 21, 202613 min read
Lifestyle & Healthy HabitsWhat 12 Weeks of Growth Hormone Peptide Therapy Results Look Like in a Metabolic Patient: Real Biomarker Data
Growth hormone peptide therapy results are measurable — and they show up on labs. This case study walks through 12 weeks of a CJC-1295/ipamorelin protocol in a metabolic patient: baseline biomarkers, week-by-week timeline, and the final numbers across IGF-1, HOMA-IR, triglycerides, and fasting insulin. If you want to know what real outcomes look like before you start, this is the data.
Editorial TeamMay 20, 202613 min read
Lifestyle & Healthy HabitsBPC-157 Injection vs Oral Peptide: Injectable, Oral, and Nasal Delivery Methods Compared — Which Is Right for Your Goal?
Comparing BPC-157 injection vs oral peptide delivery? This guide breaks down injectable, oral, and nasal BPC-157 by bioavailability, best use case, and clinical evidence — so you can match the method to your goal.
Lilian E.May 19, 202612 min read
LongevityCJC-1295 and Ipamorelin Stack: How This Growth Hormone Combo Supports Fat Loss and Recovery
The CJC-1295 ipamorelin stack benefits active adults 35+ seeking better body composition, faster recovery, and deeper sleep — by amplifying growth hormone output through two complementary pathways. This deep dive covers the mechanism, clinical evidence, dosing framework, monitoring requirements, and honest risk profile of this popular growth hormone secretagogue stack.
Karyn O.May 19, 202611 min read
Hormones & MetabolismPeptides for Metabolic Syndrome: A Clinician's Framework for Selecting the Right Therapy
Peptides for metabolic syndrome aren't a single solution — they're a category of targeted therapies, each acting on a different biological pathway. This deep dive covers the clinical evidence behind GLP-1 receptor agonists, tesamorelin, and how the PMOS rename (formerly PCOS) changes the treatment framework for women. Includes a selection framework, comparison table, and expert guidance on monitoring.
Dr. Priyali Singh, MDMay 18, 202612 min read
LongevityEpithalon Peptide Longevity: Anti-Aging Science or Overhyped Supplement?
Epithalon peptide longevity research spans 40+ years, telomere activation studies, and early human trials. This deep dive separates the real science from the supplement hype — covering mechanisms, evidence quality, safety, and what serious longevity protocols should actually include.
Editorial TeamMay 18, 202614 min read
Hormones & MetabolismThe KLOW Peptide Stack and GLP-1 Therapy: What the Evidence Actually Shows
If you are on semaglutide, tirzepatide, or any GLP-1 receptor agonist and you have spent time in health forums recently, you have almost certainly encountered the acronym KLOW. Peptide stacks are one of the fastest-growing conversations among patients optimising their weight loss journey — and KLOW sits at the centre of that discussion...
Editorial TeamMay 15, 202618 min read
Hormones & MetabolismPCOS Is Now PMOS: What the Rename Means for Your Diagnosis, Care, and Why Peptides Are Reshaping Treatment
Here is what the rename from PCOS to PMOS means, why it matters more than a single letter, and how peptide-based therapies — particularly GLP-1 receptor agonists and kisspeptin — are now supported by growing clinical evidence for the underlying biology of this condition.
Dr. Jossy Onwude, MDMay 14, 202621 min read
Weight ManagementTesamorelin: The FDA-Approved Peptide That Reduces Visceral Fat Without Cutting Calories
Tesamorelin visceral fat loss is backed by FDA approval and multiple randomized controlled trials. This deep dive covers how tesamorelin works as a GHRH analog, what it does to IGF-1, how much visceral fat trials actually reduced, who qualifies, what to expect from treatment, and how it compares to other metabolic interventions. For patients dealing with stubborn belly fat and metabolic syndrome.
Editorial TeamMay 14, 202613 min read
Hormones & MetabolismBPC-157 and the Gut: How This Peptide Repairs the Intestinal Lining and Reduces Inflammation
BPC-157 gut health research reveals a 15-amino-acid peptide derived from gastric juice that repairs the intestinal lining, counteracts leaky gut syndrome, reduces inflammatory cytokines, and protects against NSAID-induced gut damage. This deep dive covers the mechanisms, evidence, and what it means for patients.
Dr. Jossy Onwude, MDMay 13, 202613 min read
Lifestyle & Healthy HabitsGLP-1 Telehealth Provider Comparison: Which Platforms Actually Monitor You Properly?
A clinical GLP-1 telehealth provider comparison for 2026. See how Hims, Ro, Calibrate, Mochi Health, and Meto compare on lab requirements, specialist access, monitoring cadence, and insurance coverage — before you enrol.
Dr. Jossy Onwude, MDMay 13, 202614 min read